AU2003210125B2 - Use of polysaccharide derivatives as anti-infective substances - Google Patents

Use of polysaccharide derivatives as anti-infective substances Download PDF

Info

Publication number
AU2003210125B2
AU2003210125B2 AU2003210125A AU2003210125A AU2003210125B2 AU 2003210125 B2 AU2003210125 B2 AU 2003210125B2 AU 2003210125 A AU2003210125 A AU 2003210125A AU 2003210125 A AU2003210125 A AU 2003210125A AU 2003210125 B2 AU2003210125 B2 AU 2003210125B2
Authority
AU
Australia
Prior art keywords
starch
sub
benzyl
alkyl
quab
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003210125A
Other languages
English (en)
Other versions
AU2003210125A1 (en
Inventor
Hans-Martin Dahse
Vera Haack
Albert Hartl
Thomas Heinze
Ute Mollmann
Michaela Schmidtke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Global Technologies LLC
Original Assignee
Dow Global Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies LLC filed Critical Dow Global Technologies LLC
Publication of AU2003210125A1 publication Critical patent/AU2003210125A1/en
Assigned to DOW WOLFF CELLULOSICS GMBH reassignment DOW WOLFF CELLULOSICS GMBH Alteration of Name(s) of Applicant(s) under S113 Assignors: WOLFF CELLULOSICS GMBH & CO. KG
Application granted granted Critical
Publication of AU2003210125B2 publication Critical patent/AU2003210125B2/en
Assigned to DOW GLOBAL TECHNOLOGIES INC. reassignment DOW GLOBAL TECHNOLOGIES INC. Request for Assignment Assignors: DOW WOLFF CELLULOSICS GMBH
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/719—Pullulans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
AU2003210125A 2002-01-10 2003-01-10 Use of polysaccharide derivatives as anti-infective substances Ceased AU2003210125B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10200717.9 2002-01-10
DE10200717A DE10200717A1 (de) 2002-01-10 2002-01-10 Verwendung von Polysaccharid-Derivaten als antiinfektive Substanzen
PCT/DE2003/000095 WO2003057227A1 (de) 2002-01-10 2003-01-10 Verwendung von polysaccharid-derivaten als antiinfektive substanzen

Publications (2)

Publication Number Publication Date
AU2003210125A1 AU2003210125A1 (en) 2003-07-24
AU2003210125B2 true AU2003210125B2 (en) 2008-01-24

Family

ID=7711838

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003210125A Ceased AU2003210125B2 (en) 2002-01-10 2003-01-10 Use of polysaccharide derivatives as anti-infective substances

Country Status (17)

Country Link
US (1) US7297687B2 (enExample)
EP (1) EP1465640B8 (enExample)
JP (1) JP4452777B2 (enExample)
KR (1) KR100913301B1 (enExample)
CN (1) CN1615141B (enExample)
AT (1) ATE408411T1 (enExample)
AU (1) AU2003210125B2 (enExample)
BR (1) BRPI0306851A8 (enExample)
CA (1) CA2472586C (enExample)
DE (2) DE10200717A1 (enExample)
ES (1) ES2314205T3 (enExample)
MX (1) MXPA04006673A (enExample)
NO (1) NO20043265L (enExample)
PL (1) PL206600B1 (enExample)
RU (1) RU2332221C2 (enExample)
WO (1) WO2003057227A1 (enExample)
ZA (1) ZA200405400B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE476882T1 (de) * 2003-06-13 2010-08-15 Torkel Wadstroem Produkt für absorptionszwecke
CN100469707C (zh) * 2005-03-11 2009-03-18 中国石化北京燕化石油化工股份有限公司 一种高浊高铁循环冷却水的处理方法
KR101278106B1 (ko) * 2011-03-03 2013-06-24 이원실 이온성 액체를 이용한 셀룰로오스계 고분자 항균제의 제조방법
IN2014DN07422A (enExample) 2012-03-09 2015-04-24 Friedrich Schiller Universität Jena
EP3227379B1 (en) * 2014-12-02 2020-07-29 B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University Quaternized starches for use as anti-microbial agents
FR3064473B1 (fr) * 2017-04-03 2021-02-12 Basf Beauty Care Solutions France Sas Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale
EP3824896A4 (en) * 2018-07-20 2022-08-24 Shiseido Company, Ltd. VIRUS INACTIVATION AGENT
CN115260320B (zh) * 2021-04-30 2023-05-05 中国科学院化学研究所 离子型多糖衍生物用作防冰涂层材料的应用
KR102559540B1 (ko) 2022-09-19 2023-07-25 문건희 토류벽시스템용 토류벽체

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0457969A (ja) * 1990-06-27 1992-02-25 Unitika Ltd 抗菌性布帛の製造方法
WO2000026447A1 (en) * 1998-10-29 2000-05-11 Ciba Specialty Chemicals Holding Inc. Incorporation of organic anti-microbials into fibres during a fibre spinning process
US6306835B1 (en) * 1997-09-23 2001-10-23 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Biocidal chitosan derivatives

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60203265A (ja) * 1984-03-28 1985-10-14 ダイセル化学工業株式会社 抗血液凝固性高分子材料
DE3711680A1 (de) * 1987-04-07 1988-10-27 Hoechst Ag Waessrige biozide kationische kunststoffdispersionen und deren verwendung als fungizide, bakterizide und algizide ausruestungsmittel
DE3720555A1 (de) * 1987-06-22 1989-01-05 Henkel Kgaa Verwendung von unloeslichen, polyfunktionellen quartaeren ammoniumverbindungen zur adsorptiven bindung von mikroorganismen
IT1231168B (it) * 1989-07-21 1991-11-22 Texcontor Ets Copolimeri saccaridici aventi attivita' antibatterica.
IT1249309B (it) * 1991-05-03 1995-02-22 Faricerca Spa Polisaccaridi di tipo cationico
US5731259A (en) * 1991-05-03 1998-03-24 Societa Consortile Ricerche Angelini S.P.A. Cationic polysaccharides
GB2262531B (en) * 1991-12-17 1995-12-06 Erba Carlo Spa Antiviral sulphated polysaccharides
JPH05295002A (ja) * 1992-04-23 1993-11-09 Nichiden Kagaku Kk 抗菌性澱粉、水溶性多糖類及びその製造方法
ZA947572B (en) * 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
RU2098114C1 (ru) * 1995-02-03 1997-12-10 Музыка Владислав Иванович Препарат, воздействующий на функциональную активность клеток эукариот и прокариот
JPH10155898A (ja) * 1996-11-26 1998-06-16 Toyobo Co Ltd 抗菌性付与抗血栓性材料
US6096291A (en) 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
CA2268464A1 (en) * 1998-04-09 1999-10-09 National Starch And Chemical Investment Holding Corporation Nonionically derivatized starches and their use in non-aerosol, low voc hair cosmetic compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0457969A (ja) * 1990-06-27 1992-02-25 Unitika Ltd 抗菌性布帛の製造方法
US6306835B1 (en) * 1997-09-23 2001-10-23 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Biocidal chitosan derivatives
WO2000026447A1 (en) * 1998-10-29 2000-05-11 Ciba Specialty Chemicals Holding Inc. Incorporation of organic anti-microbials into fibres during a fibre spinning process

Also Published As

Publication number Publication date
CA2472586A1 (en) 2003-07-17
MXPA04006673A (es) 2004-11-10
WO2003057227A1 (de) 2003-07-17
ATE408411T1 (de) 2008-10-15
BRPI0306851A8 (pt) 2017-04-25
AU2003210125A1 (en) 2003-07-24
RU2332221C2 (ru) 2008-08-27
CN1615141B (zh) 2013-08-14
CA2472586C (en) 2011-03-15
JP2005519057A (ja) 2005-06-30
EP1465640B8 (de) 2009-04-01
KR20040079415A (ko) 2004-09-14
ES2314205T3 (es) 2009-03-16
EP1465640A1 (de) 2004-10-13
NO20043265L (no) 2004-08-04
US7297687B2 (en) 2007-11-20
KR100913301B1 (ko) 2009-08-26
CN1615141A (zh) 2005-05-11
BRPI0306851A2 (pt) 2016-11-16
RU2004124389A (ru) 2005-05-10
DE50310510D1 (de) 2008-10-30
PL370887A1 (en) 2005-05-30
US20050054609A1 (en) 2005-03-10
JP4452777B2 (ja) 2010-04-21
EP1465640B1 (de) 2008-09-17
DE10200717A1 (de) 2003-07-31
PL206600B1 (pl) 2010-08-31
ZA200405400B (en) 2005-11-30

Similar Documents

Publication Publication Date Title
US7115576B2 (en) Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate
AU642023B2 (en) Anti-virus agent
CA2472586C (en) Use of polysaccharide derivatives as antiinfective substances
US20180127516A1 (en) Novel esterified cellulose ethers of very high molecular weight
WO2014031448A1 (en) Process for preparing an ester of a cellulose ether in the presence of an alkali metal carboxylate
WO2014031446A1 (en) Process of preparing an esterified cellulose ether in the presence of an alkali metal carboxylate and an aliphatic carboxylic acid
WO2014137778A1 (en) Novel esterified cellulose ethers of very low viscosity
CN101156868A (zh) 一种抑菌护理用品
WO2016069338A1 (en) Process for producing a cellulose ether acetate succinate
US20180214412A1 (en) Immediate release cannabinoid formulations
US6933380B2 (en) Excipients containing low residual solvent and method for producing the same
Sosa‐Santillán et al. Synthesis, characterization, and antibacterial activities of novel starch derivatives against E. coli and S. aureus
NZ533960A (en) Use of polysaccharide derivatives as anti-infective substances
CN107427467B (zh) 酯化纤维素醚的水溶液
JPH06321927A (ja) 抗腫瘍ミトキサントロンのポリマー組成物
HK1074795A (en) Use of polysaccharide derivatives as anti-infective substances
EP0288019B1 (en) Beta-cyclodextrin complexes having anti-mycotic activity
EP2943224A1 (en) Voriconazole inclusion complexes
Pereira Synthesis of new pullulan derivatives for drug delivery
KR20180010354A (ko) 수용성 다당류 및 항산화제를 포함하는 복합체

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: DOW GLOBAL TECHNOLOGIES INC.

Free format text: FORMER OWNER WAS: DOW WOLFF CELLULOSICS GMBH

MK14 Patent ceased section 143(a) (annual fees not paid) or expired